Literature DB >> 28444120

Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women.

Lauren C Peres, Anthony J Alberg, Elisa V Bandera, Jill Barnholtz-Sloan, Melissa Bondy, Michele L Cote, Ellen Funkhouser, Patricia G Moorman, Edward S Peters, Ann G Schwartz, Paul D Terry, Sarah E Abbott, Fabian Camacho, Frances Wang, Joellen M Schildkraut.   

Abstract

Although the inverse association between hysterectomy and epithelial ovarian cancer (EOC) was considered well established, investigators in recent studies including women diagnosed after 2000 have observed modest increases in risk. Most studies have been conducted in white women with little representation of African-American women. We examined the relationship between premenopausal hysterectomy and EOC in African-American women and explored whether hormone therapy (HT) modified this association in 614 cases and 743 controls enrolled in the African American Cancer Epidemiology Study (2010-2015). Premenopausal hysterectomy was inversely associated with the odds of EOC (odds ratio (OR) = 0.75, 95% confidence interval (CI): 0.56, 1.01). Qualitative interaction by estrogen-only HT was present; among never users of estrogen-only HT, premenopausal hysterectomy was associated with a significantly decreased odds of EOC (OR = 0.65, 95% CI: 0.46, 0.92), whereas among users of estrogen-only HT, a positive association was observed (OR = 1.71, 95% CI: 0.76, 3.84). In a population of African-American women diagnosed after 2000, our overall results are consistent with the inverse association observed in the era before 2000, yet the effect modification by HT suggests that HT use among women who have had hysterectomies may negate the protective effects of hysterectomy on EOC, creating the appearance of a null or slightly increased risk.
© The Author 2017. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  African Americans; hormone therapy; hysterectomy; ovarian cancer

Mesh:

Year:  2017        PMID: 28444120      PMCID: PMC5860195          DOI: 10.1093/aje/kwx055

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  36 in total

1.  Effect of hysterectomy with ovarian preservation on ovarian function.

Authors:  Patricia G Moorman; Evan R Myers; Joellen M Schildkraut; Edwin S Iversen; Frances Wang; Nicolette Warren
Journal:  Obstet Gynecol       Date:  2011-12       Impact factor: 7.661

2.  Hormone therapy and ovarian cancer: incidence and survival.

Authors:  Karen J Wernli; Polly A Newcomb; John M Hampton; Amy Trentham-Dietz; Kathleen M Egan
Journal:  Cancer Causes Control       Date:  2008-02-09       Impact factor: 2.506

3.  The association of hysterectomy and menopause: a prospective cohort study.

Authors:  Cynthia M Farquhar; Lynn Sadler; Sally A Harvey; Alistair W Stewart
Journal:  BJOG       Date:  2005-07       Impact factor: 6.531

4.  Hormone therapy prescribing patterns in the United States.

Authors:  Diana S M Buist; Katherine M Newton; Diana L Miglioretti; Kevin Beverly; Maureen T Connelly; Susan Andrade; Cynthia L Hartsfield; Feifei Wei; K Arnold Chan; Larry Kessler
Journal:  Obstet Gynecol       Date:  2004-11       Impact factor: 7.661

5.  Ovarian cancer risk factors in African-American and white women.

Authors:  Patricia G Moorman; Rachel T Palmieri; Lucy Akushevich; Andrew Berchuck; Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2009-07-15       Impact factor: 4.897

6.  Effect of various forms of postmenopausal hormone therapy on the risk of ovarian cancer--a population-based case control study from Finland.

Authors:  Virpi Koskela-Niska; Eero Pukkala; Heli Lyytinen; Olavi Ylikorkala; Tadeusz Dyba
Journal:  Int J Cancer       Date:  2013-04-16       Impact factor: 7.396

7.  Black-White differences in hysterectomy prevalence: the CARDIA study.

Authors:  Julie K Bower; Pamela J Schreiner; Barbara Sternfeld; Cora E Lewis
Journal:  Am J Public Health       Date:  2008-12-04       Impact factor: 9.308

8.  A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010.

Authors:  Brian L Sprague; Amy Trentham-Dietz; Kathleen A Cronin
Journal:  Obstet Gynecol       Date:  2012-09       Impact factor: 7.661

9.  Association of exogenous estrogen and endometrial carcinoma.

Authors:  D C Smith; R Prentice; D J Thompson; W L Herrmann
Journal:  N Engl J Med       Date:  1975-12-04       Impact factor: 91.245

10.  Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis.

Authors:  Susan J Jordan; Adèle C Green; David C Whiteman; Suzanne P Moore; Christopher J Bain; Dorota M Gertig; Penelope M Webb
Journal:  Int J Cancer       Date:  2008-04-01       Impact factor: 7.396

View more
  4 in total

1.  The Association Between Hysterectomy and Ovarian Cancer Risk: A Population-Based Record-Linkage Study.

Authors:  Suzanne C Dixon-Suen; Penelope M Webb; Louise F Wilson; Karen Tuesley; Louise M Stewart; Susan J Jordan
Journal:  J Natl Cancer Inst       Date:  2019-10-01       Impact factor: 13.506

2.  Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association.

Authors:  Lilah Khoja; Rachel Palmieri Weber; Penelope M Webb; Susan J Jordan; Aruna Muthukumar; Jenny Chang-Claude; Renée T Fortner; Allan Jensen; Susanne K Kjaer; Harvey Risch; Jennifer Anne Doherty; Holly R Harris; Marc T Goodman; Francesmary Modugno; Kirsten Moysich; Andrew Berchuck; Joellen M Schildkraut; Daniel Cramer; Kathryn L Terry; Hoda Anton-Culver; Argyrios Ziogas; Minh Tung Phung; Gillian E Hanley; Anna H Wu; Bhramar Mukherjee; Karen McLean; Kathleen Cho; Malcolm C Pike; Celeste Leigh Pearce; Alice W Lee
Journal:  Gynecol Oncol       Date:  2021-11-12       Impact factor: 5.304

3.  Racial Differences in Population Attributable Risk for Epithelial Ovarian Cancer in the OCWAA Consortium.

Authors:  Lauren C Peres; Traci N Bethea; Tareq F Camacho; Elisa V Bandera; Alicia Beeghly-Fadiel; Deanna L Chyn; Holly R Harris; Charlotte E Joslin; Patricia G Moorman; Evan Myers; Heather M Ochs-Balcom; Will Rosenow; V Wendy Setiawan; Anna H Wu; Lynn Rosenberg; Joellen M Schildkraut
Journal:  J Natl Cancer Inst       Date:  2021-06-01       Impact factor: 13.506

4.  Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.

Authors:  Lauren C Peres; Harvey Risch; Kathryn L Terry; Penelope M Webb; Marc T Goodman; Anna H Wu; Anthony J Alberg; Elisa V Bandera; Jill Barnholtz-Sloan; Melissa L Bondy; Michele L Cote; Ellen Funkhouser; Patricia G Moorman; Edward S Peters; Ann G Schwartz; Paul D Terry; Ani Manichaikul; Sarah E Abbott; Fabian Camacho; Susan J Jordan; Christina M Nagle; Mary Anne Rossing; Jennifer A Doherty; Francesmary Modugno; Kirsten Moysich; Roberta Ness; Andrew Berchuck; Linda Cook; Nhu Le; Angela Brooks-Wilson; Weiva Sieh; Alice Whittemore; Valerie McGuire; Joseph Rothstein; Hoda Anton-Culver; Argyrios Ziogas; Celeste L Pearce; Chiuchen Tseng; Malcom Pike; Joellen M Schildkraut
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 9.685

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.